Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

1700753

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:31:45
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:39:31 22/04/2024 16:13:06
	hansard heading	Lecanemab: Licensing
	house id	2
	identifier	HL3793
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:41:59
	question text	To ask His Majesty's Government whether they intend to license the drug Lecanemab for the treatment of dementia and Alzheimer’s disease; and if so, when.
	session	2023/24
	session number	4
	tabling member printed	Baroness Ritchie of Downpatrick
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3793
	type	WrittenParliamentaryQuestion
	uin	HL3793
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4130 label Biography information for Baroness Ritchie of Downpatrick
	publisher	25277
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1700775

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:21
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:26 22/04/2024 16:13:12
	hansard heading	Surgery: Standards
	house id	2
	identifier	HL3727
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:41:25
	question text	To ask His Majesty's Government what assessment they have made of the recent proposals of the Centre for Perioperative Care to address inefficiencies in the surgical pathway.
	session	2023/24
	session number	4
	tabling member printed	Baroness Burt of Solihull
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3727
	type	WrittenParliamentaryQuestion
	uin	HL3727
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1567 label Biography information for Baroness Burt of Solihull
	publisher	25277
	tabling member	1567 label Biography information for Baroness Burt of Solihull

1700774

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:17
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:24 22/04/2024 16:12:04
	hansard heading	Surgery: Standards
	house id	2
	identifier	HL3726
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:40:13
	question text	To ask His Majesty's Government what steps they are taking to introduce better perioperative practices into the NHS to reduce the number of surgical cancellations, complications, and extended stays in hospital.
	session	2023/24
	session number	4
	tabling member printed	Baroness Burt of Solihull
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3726
	type	WrittenParliamentaryQuestion
	uin	HL3726
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1567 label Biography information for Baroness Burt of Solihull
	publisher	25277
	tabling member	1567 label Biography information for Baroness Burt of Solihull

1700683

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:26:23
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:35:49 22/04/2024 16:11:11
	hansard heading	NHS: Staff
	house id	2
	identifier	HL3741
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:39:17
	question text	To ask His Majesty's Government what is their assessment of the impact of the NHS long-term workforce plan upon the number of specialists such as Parkinson’s nurses in the NHS.
	session	2023/24
	session number	4
	tabling member printed	Baroness Gale
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3741
	type	WrittenParliamentaryQuestion
	uin	HL3741
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2503 label Biography information for Baroness Gale
	publisher	25277
	tabling member	2503 label Biography information for Baroness Gale

1700672

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:26:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:35:18 22/04/2024 15:47:13
	hansard heading	Olanzapine: Shortages
	house id	2
	identifier	HL3730
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:15:21
	question text	To ask His Majesty's Government what assessment they have made of the impact of the shortage of the psychotropic medication Olanzapine, and what steps they are taking to ensure that such shortages do not affect the health and safety of patients, and wider public safety.
	session	2023/24
	session number	4
	tabling member printed	Lord Carlile of Berriew
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3730
	type	WrittenParliamentaryQuestion
	uin	HL3730
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1138 label Biography information for Lord Carlile of Berriew
	publisher	25277
	tabling member	1138 label Biography information for Lord Carlile of Berriew

1700671

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:26:01
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:35:15 22/04/2024 15:47:16
	hansard heading	Drugs: Shortages
	house id	2
	identifier	HL3729
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:15:21
	question text	To ask His Majesty's Government what steps they are taking to mitigate the current shortage of the psychotropic medication Olanzapine, Risperidone and Haloperidol following the sudden departure of two generic manufacturers from the UK market.
	session	2023/24
	session number	4
	tabling member printed	Lord Carlile of Berriew
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3729
	type	WrittenParliamentaryQuestion
	uin	HL3729
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1138 label Biography information for Lord Carlile of Berriew
	publisher	25277
	tabling member	1138 label Biography information for Lord Carlile of Berriew

1700777

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:34 22/04/2024 15:46:11
	hansard heading	Incontinence: Drugs
	house id	2
	identifier	HL3749
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:14:34
	question text	To ask His Majesty's Government what plans they have to consult patients, clinicians and manufacturers on the categorisation of products available on Part IX of the Drug Tariff as proposed in the recent consultation paper; and what assessment they have made of the impact of the proposed changes to Drug Tariff Part IX on (1) patients with continence care needs, (2) continence care services, (3) the range of devices available to clinicians and patients, and (4) new product development and innovation in medical devices in the continence sector.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3749
	type	WrittenParliamentaryQuestion
	uin	HL3749
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1700776

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:36:23
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:45:30 22/04/2024 15:46:13
	hansard heading	Drugs: Prices
	house id	2
	identifier	HL3748
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:14:34
	question text	To ask His Majesty's Government when they will publish a timeline for the implementation of the proposed changes to Drug Tariff Part IX; provide the definition of "quality" that will be used as part of the enhanced assessment process included in those proposed changes; and publish in full the responses received to that consultation.
	session	2023/24
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3748
	type	WrittenParliamentaryQuestion
	uin	HL3748
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1700675

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:26:08
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:35:25 22/04/2024 15:37:08
	hansard heading	Tofersen
	house id	2
	identifier	HL3733
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:05:49
	question text	To ask His Majesty's Government what consideration was given to the costs of complicated grief in families of patients dying from SOD-1 MND during the evaluation process that led to the decision to decline access to tofersen for NHS patients.
	session	2023/24
	session number	4
	tabling member printed	Baroness Finlay of Llandaff
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3733
	type	WrittenParliamentaryQuestion
	uin	HL3733
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3609 label Biography information for Baroness Finlay of Llandaff
	publisher	25277
	tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1700674

	human indexable
	published
	registered interest
	answer date	29/04/2024
	date	15/04/2024
	date tabled	15/04/2024
	ddp created	15/04/2024 20:26:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/04/2024 20:35:23 22/04/2024 15:37:10
	hansard heading	Tofersen: Licensing
	house id	2
	identifier	HL3732
	legislature	25277
	parliament number	58
	question first answered	22/04/2024 15:05:49
	question text	To ask His Majesty's Government what assessment they have made of the negative impact on pharmaceutical research investment in the UK of the refusal by National Institute for Health and Care Excellence to approve tofersen for SOD-1 MND patients in the UK.
	session	2023/24
	session number	4
	tabling member printed	Baroness Finlay of Llandaff
	title	House of Lords Tabled Parliamentary Question 2023/24 HL3732
	type	WrittenParliamentaryQuestion
	uin	HL3732
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3609 label Biography information for Baroness Finlay of Llandaff
	publisher	25277
	tabling member	3609 label Biography information for Baroness Finlay of Llandaff